| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ra Medical Systems, Inc. | CFO | Common Stock | 21,680 | $8,676 | $0.4002 | 20 May 2022 | Direct |
| Calidi Biotherapeutics, Inc. | Chief Financial Officer | Common Stock | 2,500 | $1,475 | $0.5900 | 21 Aug 2025 | Direct |
| Brooklyn ImmunoTherapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 664,800 | 03 Jun 2022 | Direct | ||
| Calidi Biotherapeutics, Inc. | Chief Financial Officer | Stock Options (right to buy) | 30,000 | 03 Sep 2025 | Direct | ||
| Calidi Biotherapeutics, Inc. | Chief Financial Officer | Warrant (right to buy) | 2,500 | 21 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | 03 Sep 2025 | 1 | $0 | 4 | Chief Financial Officer | 05 Sep 2025, 19:56 |
| CLDI | Calidi Biotherapeutics, Inc. | 21 Aug 2025 | 2 | +$5,000 | 4 | Chief Financial Officer | 25 Aug 2025, 20:47 |
| CLDI | Calidi Biotherapeutics, Inc. | 17 Jun 2024 | 1 | $0 | 4 | Chief Financial Officer | 20 Jun 2024, 20:56 |
| CLDI | Calidi Biotherapeutics, Inc. | 30 Oct 2023 | 0 | $0 | 3 | Chief Financial Officer | 02 Nov 2023, 12:26 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 03 Jun 2022 | 1 | $0 | 4 | Chief Financial Officer | 06 Jun 2022, 17:01 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 31 May 2022 | 0 | $0 | 3 | Chief Financial Officer | 01 Jun 2022, 17:00 |
| RMED | Ra Medical Systems, Inc. | 20 May 2022 | 1 | -$410 | 4 | CFO | 24 May 2022, 16:33 |
| RMED | Ra Medical Systems, Inc. | 20 Nov 2021 | 2 | -$7,032 | 4 | CFO | 24 Nov 2021, 15:03 |